Efficacy and safety of liraglutide and semaglutide in obese children and adolescents: a systematic review
Liraglutide and semaglutide demonstrate significant superiority over placebo in reducing body weight and body mass index in obese children and adolescents and substantiate therapy in pediatric practice with careful assessment of the benefit-risk ratio.